Search
Descriptor English: Gemcitabine
Descriptor Spanish: Gemcitabina
Descriptor gemcitabina
Entry term(s) 2',2'-DFDC
2',2'-difluoro-2'-desoxicitidina
2',2'-difluorodesoxicitidina
2'-desoxi-2',2''-difluorocitidina-5'-O-monofosfato
2'-desoxi-2'-difluorocitidina
Gemzar
LY 188011
LY-188011
clorhidrato de gemcitabina
dFdCyd
isómero D-treo-pentafuranosil de la gemcitabina
isómero alfa-D-treo-pentafuranosil de la gemcitabina
isómero beta-D-treo-pentafuranosil de la gemcitabina
Scope note: Antimetabolito desoxicitidínico utilizado como antineoplásico.
Descriptor Portuguese: Gencitabina
Descriptor French: Gemcitabine
Entry term(s): 188011, LY
2' Deoxy 2' Difluorocytidine
2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate
2',2'-DFDC
2',2'-Difluoro-2'-Deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate
2'-Deoxy-2'-Difluorocytidine
Gemcitabine Hydrochloride
Gemcitabine, (D-threo-pentafuranosyl)-Isomer
Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer
Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer
Gemicitabine
Gemzar
Hydrochloride, Gemcitabine
LY 188011
LY-188011
dFdCyd
Tree number(s): D03.258
D03.383.742.680.245.500.775
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000093542
Scope note: A deoxycytidine antimetabolite used as an antineoplastic agent.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antimetabolites, Antineoplastic
Public MeSH Note: 2023; GEMCITABINE was indexed under DEOXYCYTIDINE 1988-2022
History Note: 2023 (1988)
DeCS ID: 60181
Unique ID: D000093542
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2023/01/01
Date of Entry: 2022/07/14
Revision Date: 2022/07/14
Gemcitabine - Preferred
Concept UI M000754277
Scope note A deoxycytidine antimetabolite used as an antineoplastic agent.
Preferred term Gemcitabine
Entry term(s) 2' Deoxy 2' Difluorocytidine
2',2'-DFDC
2',2'-Difluoro-2'-Deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-2'-Difluorocytidine
Gemicitabine
dFdCyd
Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer - Narrower
Concept UI M0323771
Preferred term Gemcitabine, (beta-D-threo-pentafuranosyl)-Isomer
LY 188011 - Narrower
Concept UI M0158475
Preferred term LY 188011
Entry term(s) 188011, LY
LY-188011
Gemcitabine Hydrochloride - Narrower
Concept UI M0585172
Preferred term Gemcitabine Hydrochloride
Entry term(s) Hydrochloride, Gemcitabine
Gemcitabine, (D-threo-pentafuranosyl)-Isomer - Narrower
Concept UI M0323773
Preferred term Gemcitabine, (D-threo-pentafuranosyl)-Isomer
Gemzar - Narrower
Concept UI M0158474
Preferred term Gemzar
Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer - Narrower
Concept UI M0323772
Preferred term Gemcitabine, (alpha-D-threo-pentofuranosyl)-Isomer
2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate - Narrower
Concept UI M0373925
Preferred term 2'-Deoxy-2',2''-Difluorocytidine-5'-O-Monophosphate
Entry term(s) 2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey